Mutations and aberrant expression patterns of BCL-6 corepressor (BCOR) and mixed lineage leukemia 2 (MLL2) have been implicated in NKTCL [115, 116]. The gene discussed is BCOR; the disease is extranodal nasal NK/T cell lymphoma.